Global Human Genetics Market Overview:
Global Human Genetics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Human Genetics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Human Genetics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Human Genetics Market:
The Human Genetics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Human Genetics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Human Genetics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Human Genetics market has been segmented into:
Wellness & E-Commerce
Preventive Medicine
Diagnostic & Treatment
By Application, Human Genetics market has been segmented into:
NIPT
Carrier Testing
Pharmacogenomic Testing
Karyotype Testing
Thrombophilia Testing
Septin 9 Biomarker Testing
NGS
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Human Genetics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Human Genetics market.
Top Key Players Covered in Human Genetics market are:
Myriad Genetics (US)
Synlab Group (Germany)
Eurofins Megalab S.A (Spain)
Biomarker Technology (US)
Echevarne Laboratory(Spain)
Elabscience Biotechnology Inc (US)
NIMGenetics (Spain)
Sistemas Genómicos (Spain)
FullGenomics (Spain)
GENinCode(UK)
Atrys Health (Spain)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Human Genetics Market Type
4.1 Human Genetics Market Snapshot and Growth Engine
4.2 Human Genetics Market Overview
4.3 Wellness & E-Commerce
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Wellness & E-Commerce: Geographic Segmentation Analysis
4.4 Preventive Medicine
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Preventive Medicine: Geographic Segmentation Analysis
4.5 Diagnostic & Treatment
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Diagnostic & Treatment: Geographic Segmentation Analysis
Chapter 5: Human Genetics Market Application
5.1 Human Genetics Market Snapshot and Growth Engine
5.2 Human Genetics Market Overview
5.3 NIPT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 NIPT: Geographic Segmentation Analysis
5.4 Carrier Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Carrier Testing: Geographic Segmentation Analysis
5.5 Pharmacogenomic Testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Pharmacogenomic Testing: Geographic Segmentation Analysis
5.6 Karyotype Testing
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Karyotype Testing: Geographic Segmentation Analysis
5.7 Thrombophilia Testing
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Thrombophilia Testing: Geographic Segmentation Analysis
5.8 Septin 9 Biomarker Testing
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Septin 9 Biomarker Testing: Geographic Segmentation Analysis
5.9 NGS
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 NGS: Geographic Segmentation Analysis
5.10 Others
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Human Genetics Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MYRIAD GENETICS (US)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 SYNLAB GROUP (GERMANY)
6.4 EUROFINS MEGALAB S.A (SPAIN)
6.5 BIOMARKER TECHNOLOGY (US)
6.6 ECHEVARNE LABORATORY(SPAIN)
6.7 ELABSCIENCE BIOTECHNOLOGY INC (US)
6.8 NIMGENETICS (SPAIN)
6.9 SISTEMAS GENÓMICOS (SPAIN)
6.10 FULLGENOMICS (SPAIN)
6.11 GENINCODE(UK)
6.12 ATRYS HEALTH (SPAIN)
Chapter 7: Global Human Genetics Market By Region
7.1 Overview
7.2. North America Human Genetics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Wellness & E-Commerce
7.2.2.2 Preventive Medicine
7.2.2.3 Diagnostic & Treatment
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 NIPT
7.2.3.2 Carrier Testing
7.2.3.3 Pharmacogenomic Testing
7.2.3.4 Karyotype Testing
7.2.3.5 Thrombophilia Testing
7.2.3.6 Septin 9 Biomarker Testing
7.2.3.7 NGS
7.2.3.8 Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Human Genetics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Wellness & E-Commerce
7.3.2.2 Preventive Medicine
7.3.2.3 Diagnostic & Treatment
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 NIPT
7.3.3.2 Carrier Testing
7.3.3.3 Pharmacogenomic Testing
7.3.3.4 Karyotype Testing
7.3.3.5 Thrombophilia Testing
7.3.3.6 Septin 9 Biomarker Testing
7.3.3.7 NGS
7.3.3.8 Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Human Genetics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Wellness & E-Commerce
7.4.2.2 Preventive Medicine
7.4.2.3 Diagnostic & Treatment
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 NIPT
7.4.3.2 Carrier Testing
7.4.3.3 Pharmacogenomic Testing
7.4.3.4 Karyotype Testing
7.4.3.5 Thrombophilia Testing
7.4.3.6 Septin 9 Biomarker Testing
7.4.3.7 NGS
7.4.3.8 Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Human Genetics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Wellness & E-Commerce
7.5.2.2 Preventive Medicine
7.5.2.3 Diagnostic & Treatment
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 NIPT
7.5.3.2 Carrier Testing
7.5.3.3 Pharmacogenomic Testing
7.5.3.4 Karyotype Testing
7.5.3.5 Thrombophilia Testing
7.5.3.6 Septin 9 Biomarker Testing
7.5.3.7 NGS
7.5.3.8 Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Human Genetics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Wellness & E-Commerce
7.6.2.2 Preventive Medicine
7.6.2.3 Diagnostic & Treatment
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 NIPT
7.6.3.2 Carrier Testing
7.6.3.3 Pharmacogenomic Testing
7.6.3.4 Karyotype Testing
7.6.3.5 Thrombophilia Testing
7.6.3.6 Septin 9 Biomarker Testing
7.6.3.7 NGS
7.6.3.8 Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Human Genetics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Wellness & E-Commerce
7.7.2.2 Preventive Medicine
7.7.2.3 Diagnostic & Treatment
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 NIPT
7.7.3.2 Carrier Testing
7.7.3.3 Pharmacogenomic Testing
7.7.3.4 Karyotype Testing
7.7.3.5 Thrombophilia Testing
7.7.3.6 Septin 9 Biomarker Testing
7.7.3.7 NGS
7.7.3.8 Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Human Genetics Scope:
|
Report Data
|
Human Genetics Market
|
|
Human Genetics Market Size in 2025
|
USD XX million
|
|
Human Genetics CAGR 2025 - 2032
|
XX%
|
|
Human Genetics Base Year
|
2024
|
|
Human Genetics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Myriad Genetics (US), Synlab Group (Germany), Eurofins Megalab S.A (Spain), Biomarker Technology (US), Echevarne Laboratory(Spain), Elabscience Biotechnology Inc (US), NIMGenetics (Spain), Sistemas Genómicos (Spain), FullGenomics (Spain), GENinCode(UK), Atrys Health (Spain).
|
|
Key Segments
|
By Type
Wellness & E-Commerce
Preventive Medicine
Diagnostic & Treatment
By Applications
NIPT
Carrier Testing
Pharmacogenomic Testing
Karyotype Testing
Thrombophilia Testing
Septin 9 Biomarker Testing
NGS
Others
|
